The Need for Drug Safety- The Older Person and Ageism

With errors in the administration of drugs and adverse reactions accounting for more than 100,000 deaths annually, Dr. Robert N. Butler, president and CEO of the ILC-USA, addresses the urgent need for clinical trials that include older adults and careful monitoring of drugs in the years following approval by the FDA.